Skip to content

Molecular portraits of human breast tumours

Why this mattered

Before this paper, breast cancer was largely stratified by histology, grade, stage, and a small number of markers such as ER and HER2. Perou, Sørlie, Eisen and colleagues showed that genome-wide expression patterns could give each tumour a reproducible “molecular portrait,” using cDNA microarrays across thousands of genes in primary human breast tumours. The key shift was conceptual: breast cancer was not one disease with variable behavior, but a set of biologically distinct transcriptional states, visible directly from tumour RNA.

That made a new kind of oncology possible. Tumours could be grouped by coordinated gene-expression programs rather than by single markers alone, leading to the intrinsic subtype framework: luminal, basal-like, HER2-enriched, and related classes. This became a foundation for molecular taxonomy, prognostic assays, and subtype-aware clinical research, especially in distinguishing ER-positive luminal disease from basal-like/triple-negative biology.

Subsequent breast-cancer genomics, including larger expression studies and TCGA’s integrated genomic “portraits,” extended rather than replaced this idea: DNA mutations, copy-number changes, methylation, microRNA, and proteomic data were interpreted against subtype structure first made visible by expression profiling. The paper’s lasting importance is that it helped move cancer classification from microscope-centered description toward data-rich molecular diagnosis, making tumour heterogeneity a measurable organizing principle for prognosis, therapy development, and translational cancer biology.

Abstract

(no abstract available)

Sources